Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinyebaidu granules plus routine treatment for COVID-19 pneumonia
ChiCTR2000029755Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Feb 2020
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Jinyebaidu in coronavirus pneumonia (2 arms), sponsored by Tongji Hospital. Primary endpoint: Validity observation index. Started Feb 2020; status: recruiting.
02
Drugs
Jinyebaidu
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on ChiCTR2000029755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029755.